Pathogenic autoantibodies target aquaporin-4 (AQP4) water channels in individuals with neuromyelitis optica (NMO). Recently, allelic mutations were reported at residue 19 of AQP4 in three cases of NMO, and it was suggested that polymorphisms may influence disease by altering AQP4 supramolecular assembly into orthogonal arrays of particles (OAPs). We analyzed the determinants of OAP formation by human AQP4 to investigate the possible role of polymorphisms in NMO pathogenesis. NMO-associated mutations R19I and R19T in AQP4 did not affect OAP assembly, palmitoylation-dependent regulation of assembly, or NMO autoantibody binding. Residue-19 polymorphisms in AQP4 are thus unlikely to be disease relevant.
Introduction
Aquaporin-4 (AQP4) is a water channel expressed at the plasma membrane in astrocytes in the central nervous system as well as in various peripheral organs such as kidney and skeletal muscle (Frigeri et al., 1995) . AQP4 facilitates osmotically driven water transport. Phenotype analysis of AQP4 knockout mice indicated the involvement of AQP4 in brain water balance, neuroexcitation and astrocyte migration (Verkman et al., 2006) . AQP4 is the target antigen of autoantibodies in the neuroinflammatory demyelinating disease neuromyelitis optica (NMO), where pathogenic autoantibodies are thought to bind to AQP4, produce astrocyte damage, and initiate a cascade of inflammatory events resulting in myelin loss and neurological impairment (Lennon et al., 2005; Wingerchuk et al., 2007; Jarius et al., 2008) .
The AQP4 protein is expressed as two major isoforms: a long isoform, M1, with translational initiation at Met-1, and a shorter isoform, M23, with translational initiation at Met-23 (Yang et al., 1995; Lu et al., 1996) . AQP4 can form supramolecular assemblies in membranes called orthogonal arrays of particles (OAPs), which are square arrays of particles visualized by freeze-fracture electron microscopy (Wolburg, 1995) . M23 by itself forms large OAPs in transfected cells (Yang et al., 1996) , whereas M1 by itself forms few or no OAPs. However, M1 can co-associate with M23 to form mixed-composition OAPs that are smaller than the OAPs formed by M23 alone (Furman et al., 2003) . Using multiple independent techniques, we found that M1 and M23 can assemble as heterotetramers, and that OAPs are dynamic structures that are subject to regulation by second messengers and N-terminus palmitoylation at residues Cys-13 and Cys-17 (Crane et al., 2009; Tajima et al., 2010) . Truncation and mutagenesis indicated that OAP formation by M23 involves N-terminus M23-M23 inter-tetrameric interactions, and that the inability of M1 to form OAPs involves blocking of the N-terminus interaction by residues just upstream of Met-23 (Crane and Verkman, 2009) .
The causative factors in the generation of pathogenic AQP4 autoantibodies in NMO are not known. A genetic susceptibility has been proposed based on increased disease occurrence in related than unrelated persons (Matiello et al., 2010) . The possible involvement of AQP4 polymorphisms in NMO was proposed from the observation that 3 out of 172 NMO patients had mutations at Arg-19 (R19I and R19T), whereas control subjects did not (Matiello et al., 2009a, b) . Based on data that some AQP4 autoantibodies bind more tightly to OAPs than to individual AQP4 tetramers (Nicchia et al., 2009; Mader et al., 2010; Crane et al., 2011) , and on the involvement of the AQP4 N-terminus in OAP formation/disruption (Crane et al., 2009) , it was speculated that the residue-19 polymorphisms may alter OAP formation by AQP4 and hence autoantibody binding (Matiello et al., 2009a, b) . Here, we tested this possibility by a series of biophysical and biochemical measurements on native human AQP4 and human Arg-19 AQP4 mutants.
Materials and methods

DNA constructs, cell culture and transfections
DNA constructs encoding human AQP4 isoforms were generated by PCR-amplification using whole brain cDNA as template. MycJournal of Neuroimmunology 236 (2011) 93-98 
